Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31836
Title: Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution.
Austin Authors: McEwan, Tim;Bhambra, Jaspreet;Liew, David F L ;Robinson, Philip C
Affiliation: Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, QLD 4029, Australia.
University of Queensland School of Clinical Medicine, Faculty of Medicine, Herston, QLD 4029, Australia.
Rheumatology
Clinical Pharmacology and Therapeutics
Department of Medicine, University of Melbourne, Parkville VIC 3052, Australia.
Issue Date: 2023
Date: 2022-12
Publication information: Seminars in Arthritis and Rheumatism 2022
Abstract: To identify reports of colchicine-induced neuropathy and myopathy and ascertain risk factors associated with this toxicity at commonly used doses.
URI: https://ahro.austin.org.au/austinjspui/handle/1/31836
DOI: 10.1016/j.semarthrit.2022.152150
ORCID: 
Journal: Seminars in Arthritis and Rheumatism
Start page: 152150
PubMed URL: 36512928
ISSN: 1532-866X
Type: Journal Article
Subjects: Colchicine
Creatine kinase
Drug interactions
Liver dysfunction
Muscle
Myopathy
Nerve
Neuropathy
Renal dysfunction
Appears in Collections:Journal articles

Show full item record

Page view(s)

30
checked on May 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.